Core Viewpoint - The agricultural chemical sector experienced a rise of 1.83% on August 20, with Jiangshan Co., Ltd. leading the gains [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3766.21, up 1.04% [1]. - The Shenzhen Component Index closed at 11926.74, up 0.89% [1]. Group 2: Individual Stock Performance - Jiangshan Co., Ltd. (600389) closed at 24.66, with a gain of 5.61% and a trading volume of 141,200 shares, amounting to a transaction value of 342 million yuan [1]. - Yuntianhua Co., Ltd. (600096) closed at 26.95, up 5.27%, with a trading volume of 490,900 shares and a transaction value of 1.318 billion yuan [1]. - Xin'an Chemical Industry Co., Ltd. (600596) closed at 10.71, gaining 4.18%, with a trading volume of 461,300 shares and a transaction value of 483 million yuan [1]. - Batian Ecological Engineering Co., Ltd. (002170) closed at 10.49, up 3.96%, with a trading volume of 683,100 shares and a transaction value of 717 million yuan [1]. - Hubei Xuanhua Co., Ltd. (000422) closed at 13.75, gaining 3.38%, with a trading volume of 469,200 shares and a transaction value of 637 million yuan [1]. - Xianda Co., Ltd. (603086) closed at 10.57, up 3.12%, with a trading volume of 851,100 shares and a transaction value of 907 million yuan [1]. - New Agricultural Co., Ltd. (002942) closed at 19.91, gaining 3.00%, with a trading volume of 45,100 shares and a transaction value of 8.86 million yuan [1]. - Stanley Co., Ltd. (002588) closed at 9.63, up 2.77%, with a trading volume of 141,200 shares [1]. - Xingfa Group (600141) closed at 25.83, gaining 2.70%, with a trading volume of 188,300 shares and a transaction value of 484 million yuan [1]. - Runfeng Co., Ltd. (301035) closed at 68.50, up 2.70%, with a trading volume of 13,500 shares and a transaction value of 90.67 million yuan [1]. Group 3: Fund Flow Analysis - The agricultural chemical sector saw a net outflow of 82.02 million yuan from main funds, while speculative funds experienced a net inflow of 277 million yuan, and retail investors had a net outflow of 195 million yuan [2].

证券日报网讯雅本化学（300261）8月18日在互动平台回答投资者提问时表示，截至2025年8月10日，公 司股东总数为56385户。 ...

7月19日公司发布上半年业绩预告，预计实现净利润-1000.00万元至-500.00万元，变动区间为 80.77%~90.39%。（数据宝） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） 融资融券数据显示，该股最新（8月15日）两融余额为2.74亿元，其中，融资余额为2.73亿元，本期筹码 集中以来融资余额合计减少3052.00万元，降幅为10.07%。 公司发布的一季报数据显示，一季度公司共实现营业收入3.16亿元，同比增长43.52%，实现净利 润-1275.65万元，同比增长72.01%，基本每股收益为-0.0134元。 雅本化学8月18日披露，截至8月10日公司股东户数为56385户，较上期（7月31日）减少3831户，环比降 幅为6.36%。 证券时报·数据宝统计，截至发稿，雅本化学收盘价为8.01元，上涨0.63%，本期筹码集中以来股价累计 下跌9.08%。具体到各交易日，4次上涨，7次下跌。 ...

Core Viewpoint - The company emphasizes its capabilities in innovative pharmaceutical intermediates and active pharmaceutical ingredients (APIs), focusing on reducing R&D cycles and production costs for clients [1] Group 1: Company Capabilities - The company specializes in innovative pharmaceutical intermediates and raw materials, aiming to facilitate the transition from laboratory to commercial production [1] - It possesses advanced chemical synthesis and engineering capabilities, along with modular R&D production and rapid scale-up abilities [1] - The company focuses on key technology areas such as continuous flow process optimization and biocatalysis, which enhance production efficiency and optimize cost structures [1] Group 2: Facilities and Certifications - The Taicang facility is the only domestic base with API production capabilities, adhering to GMP standards and focusing on core needs of major pharmaceutical clients [1] - The Malta facility has obtained FDA certification and CEP qualification, meeting EU GMP standards for intermediates, APIs, and formulations, thus facilitating clients' international business expansion [1]

证券日报网讯 8月13日晚间，雅本化学发布公告称，公司于2025年8月12日召开第六届董事会第五次 （临时）会议，审议通过了《关于增补公司第六届董事会非独立董事的议案》，同意增补王爱军先生为 公司第六届董事会非独立董事候选人，任期自股东会审议通过之日起至第六届董事会任期届满之日止。 （编辑 任世碧） ...

证券日报网讯 8月13日晚间，雅本化学发布公告称，公司第六届董事会第五次（临时）会议审议通过了 《关于增补公司第六届董事会非独立董事的议案》《关于提请召开2025年第三次临时股东会的议案》。 （文章来源：证券日报） ...

（文章来源：证券日报） 证券日报网讯 8月13日晚间，雅本化学发布公告称，公司将于2025年8月29日召开2025年第三次临时股 东会。本次股东会将审议《关于增补公司第六届董事会非独立董事的议案》。 ...

本议案需提交 2025 年第三次临时股东会审议。 证券代码：300261 证券简称：雅本化学 公告编号：2025-059 雅本化学股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 雅本化学股份有限公司（以下简称"公司"）第六届董事会第五次（临时）会议 于 2025 年 8 月 12 日上午 10:00 以现场结合通讯方式召开，会议通知已于 2025 年 8 月 7 日以邮件方式送达全体董事。本次会议应出席董事 8 名，实际出席会议董事 8 名。会议由公司董事长兼总经理蔡彤先生主持，公司部分高级管理人员列席了会议。 本次会议的召集和召开符合《公司法》和《公司章程》的有关规定。 会议采取记名投票的方式进行表决，经与会的董事充分讨论与审议，会议形成 以下决议： 一、审议通过了《关于增补公司第六届董事会非独立董事的议案》 为确保公司治理结构的规范运作与完整性，保障董事会决策效率，董事会同意 增补财务总监王爱军先生为公司第六届董事会非独立董事候选人，任期自股东会审 议通过之日起至第六届董事会任期届满之日止。详见中国证监会指定信息披露网站 刊登的公告。本议案 ...

证券代码：300261 证券简称：雅本化学 公告编号：2025-060 雅本化学股份有限公司 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 根据雅本化学股份有限公司（以下简称"公司"）第六届董事会第五次（临 时）会议的决定，公司将于 2025 年 8 月 29 日召开公司 2025 年第三次临时股东 会，现将有关事项通知如下： 一、本次会议的基本情况 议通过，决定召开 2025 年第三次临时股东会，召集程序符合有关法律、行政法 规、部门规章、规范性文件和《公司章程》的规定。 现场会议时间：2025 年 8 月 29 日（星期五）下午 14:30 网络投票时间：2025 年 8 月 29 日 通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 8 月 29 日上午 通过深圳证券交易所互联网系统投票的具体时间为 2025 年 8 月 29 日上午 （1）现场投票：股东本人出席现场会议或通过授权委托书委托他人出席； （2）网络投票：公司将通过深圳证券交易所交易系统和互联网投票系统 （http://wltp.cninfo.com.cn）向全体股东提供网络形式的 ...

Core Viewpoint - The company has nominated Mr. Wang Aijun as a candidate for a non-independent director on the sixth board, aiming to enhance governance structure and decision-making efficiency [1]. Group 1: Board Nomination - Mr. Wang Aijun has been nominated as a non-independent director candidate for the sixth board, with the decision approved in a board meeting held on August 12, 2025 [1]. - His term will last from the date of shareholder meeting approval until the end of the sixth board's term [1]. Group 2: Background of Mr. Wang Aijun - Mr. Wang Aijun holds a master's degree and has extensive experience in finance, having served in various senior financial roles across multiple companies [1]. - He currently holds 10,500 shares directly and 300,000 shares indirectly through an employee stock ownership plan [2]. - His qualifications meet the requirements set by relevant laws and regulations, ensuring compliance with corporate governance standards [2]. Group 3: Compliance and Governance Improvements - Following a public reprimand from the Shenzhen Stock Exchange during his tenure as board secretary, the company has implemented corrective measures to enhance information disclosure practices [3]. - The company has improved its information disclosure system and conducted training for board members and senior management to strengthen compliance awareness [3]. - Mr. Wang has been the financial director since 2018, contributing significantly to the company's strategic planning and financial management [3].